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risk factor for in-hospital mortality by a
multivariate analysis.2 Reduction of the pe-
riod for each procedure, as seen in the
shorter “CABG proximal” bar in Dr Takagi
and associates’ strategy, seems to reduce
the CPB period. We are, however, afraid
that the “CABG distal” bar during the CPB
period in their strategy would become
much longer, depending on the number of
diseased coronary arteries. Recently, car-
diac surgeons are seeing more and more
elderly patients with aortic aneurysm and
multivessel coronary artery disease in civ-
ilized countries like Japan where the senior
population is growing rapidly. We recom-
mend our strategy especially for elderly
patients with comorbidities who can poorly
tolerate an elongated CPB time and still
require multiple coronary revasculariza-
tion.
For surgeons who are not fully familiar
with the OPCAB technique, here is a tip:
The patient is heparinized and cannulated
for CPB; OPCAB on the anterior cardiac
wall (the left anterior descending and diag-
onal artery) is performed first; the surgeon,
faced with some difficulties in OPCAB on
the other wall, initiates CPB to decompress
the beating heart and maintain the hemo-
dynamics. The patient has already avoided
an unnecessary CPB period.
Hitoshi Yokoyama, MD
Fukushima Medical University
Fukushima, Japan
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Pressure gradient in hemodynamics:
Is it measured in units of pressure?
To the Editor:
I read with interest the article on pulmo-
nary banding by Piluiko and colleagues1
and the relevant discussion. Piluiko and
colleagues1 repeatedly expressed values of
the “pressure gradient” across the banded
pulmonary artery in units of pressure (mil-
liliters of mercury). They thus committed
an inaccuracy common in biomedical
scripts. The correct formula for expressing
a hemodynamic gradient should be pres-
sure divided by distance (millimeters of
mercury per millimeter). Alternatively, the
term pressure gradient should be replaced
with pressure difference, the latter being
appropriate in this case because the accu-
rate computation of the former may not be
easy by conventional angiography.
Aristotle D. Protopapas, FRCS
26 Abbotts Ann Rd
Winchester, Hants SO22 6NB, United Kingdom
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Reply to the Editor:
I thank Dr Protopapas for the reminder that
the strict definition of gradient is the rate of
change of temperature, pressure, or another
variable as a function of distance. In car-
diovascular medicine we do, however,
commonly use the term pressure gradient
to describe the difference in pressure be-
tween two communicating cardiovascular
chambers. Although this latter definition
does not conform to the definition of gra-
dient contained in physics textbooks, it is
listed without apology in Stedman’s Medi-
cal Dictionary, just a few lines below the
formal physics definition of this term.1 Per-
haps primordial physicians selected the
term gradient to describe drops in pressure
across various types of vascular obstruc-
tions because it appeared more descriptive
and dramatic than the word difference. Dif-
ference falls rather dull and flat upon the
human ear. Whatever the reason, pressure
gradient, as used in our article,2 is a com-
monly used medical term that I predict will
persist because its particular meaning in
cardiovascular medicine is widely accepted
and understood. I suggest we acknowledge
that by virtue of common usage some terms
are used in different contexts to mean dif-
ferent things. Our use of the term pressure
gradient in the context of a discussion on
pulmonary artery bands was clear and un-
ambiguous.
Henry L. Waters III, MD
Chief, Cardiovascular Surgery
Children’s Hospital of Michigan
Associate Professor of Surgery
Wayne State University School of Medicine
Detroit, MI 48201
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Uses of the leukocyte-depleting filter
To the Editor:
I was interested to read Ilmakunnas and
colleagues’ recent article,1 in which they
showed that the Pall LG6 leukocyte-
depleting filter (Pall Biomedical, Ports-
mouth, United Kingdom) quite clearly does
not reduce the activation of neutrophils and
monocytes in clinical practice. As they ex-
plained, the previous literature on this sub-
ject has been quite unclear, with some find-
ing a reduction in inflammatory markers
and others finding a marked increase in
elastase.2,3 My colleagues and I4 recently
found that the LG6 filter significantly re-
duces cerebral microemboli detected by
transcranial Doppler but also raises serum
elastase. The mechanism by which the LG6
filter reduces microemboli is unknown but
unlikely to be inflammatory mediated, ac-
cording to Ilmakunnas and colleagues’ re-
sults,1 and is therefore more likely to be a
simple physical effect. Although the reduc-
tion in microemboli was not accompanied
by a significant improvement in neuropsy-
chologic outcome,4 the LG6 filter still has
the potential for benefit by reducing micro-
emboli.
Donald Whitaker, FRCS(ED)
Department of Cardiothoracic Surgery
Guy’s Hospital
London SE1 9RT, United Kingdom
References
1. Ilmakunnas M, Pesonen EJ, Ahonen J, Ramo
J, Siitonen S, Repo H. Activation of neutro-
phils and monocytes by a leukocyte-depleting
filter used throughout cardiopulmonary by-
pass. J Thorac Cardiovasc Surg. 2005;129:
851-9.
Letters to the Editor
952 The Journal of Thoracic and Cardiovascular Surgery ● September 2005
